Human Islet Research Network Grant: Beta Cell Regeneration for Type 1 Diabetes
SynopsisVersion HistoryRelated DocumentsPackage The Human Islet Research Network (HIRN) is offering this grant through its Consortium on Targeting and Regeneration (CTAR) to support cutting-edge research aimed at increasing or protecting functional human beta cell mass. This grant is specifically for developing innovative strategies for patients with Type-1 Diabetes (T1D). The focus areas include the controlled manipulation of beta cell replication, exploring islet cell plasticity, and reprogramming pancreatic non-beta cells into functional [...]